drugset / Trial / NCT05246397

Sugammadex Titration in Cardiac Surgery Patients

NCT05246397

Phase 4 Completed 100 enrolled University of Washington
NaSingle-groupOpen-labelOther

Summary

Sugammadex is frequently used to reverse the effects of neuromuscular blocking drugs. The recommended doses are 2 mg/kg or 4 mg/kg depending upon the depth of neuromuscular blockade. Clinical studies and experience have suggested that smaller doses may be effective. The purpose of this observational study is to determine the minimal effective dose of sugammadex by administering 50 mg every 5 minutes until the train-of-four ratio is 0.9 in a cohort of cardiac surgery patients, and to determine the duration of action by measuring the train-of-four every hour for up to 6 hours following reversal.

Timeline

Start
2022-02-01
Primary completion
2022-11-10
Completion
2022-11-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Sugammadex Other / unclassified 50 mg